Roles of complement C1q in pneumococcus–host interactions

Critical Reviews in Immunology

Volumn 35, Issue 3, 2015, Pages 173-184

  Agarwal, Vaibhav ^a   Blom, Anna M ^b  

^a German Research Foundation   (India)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Adherence and invasion; C1q; Colonization; Complement; Host pathogen interaction; Pneumococci

Indexed keywords

BACTERIAL PROTEIN; CELL PROTEIN; COMPLEMENT COMPONENT C1Q; VIRULENCE FACTOR;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT SYSTEM; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; STREPTOCOCCUS PNEUMONIAE; ANIMAL; IMMUNE EVASION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; RESPIRATORY SYSTEM; SYMBIOSIS; TRANSMISSION;

ANIMALS; BACTERIAL ADHESION; COMPLEMENT C1Q; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; PNEUMOCOCCAL INFECTIONS; RESPIRATORY SYSTEM; STREPTOCOCCUS PNEUMONIAE; SYMBIOSIS; VIRULENCE FACTORS;

EID: 84945578775     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.2015012177     Document Type: Article

References (92)

1. Cartwright K. Pneumococcal disease in western Europe: burden of disease, antibiotic resistance and management. Eur J Pediatr. 2002;161(4):188-95.
2. File TM. Community-acquired pneumonia. Lancet. 2003;362(9400):1991-2001.
3. Hackel M, Lascols C, Bouchillon S, Hilton B, Morgenstern D, Purdy J. Serotype prevalence and antibiotic resistance in Streptococcus pneumoniae clinical isolates among global populations. Vaccine. 2013;31(42):4881-7.
4. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893-902.
5. Bergmann S, Hammerschmidt S. Versatility of pneumococcal surface proteins. Microbiology. 2006;152(Pt 2):295-303.
6. Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev. 2008;6(4):288-301.
7. Mitchell AM, Mitchell TJ. Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect. 2010;16(5):411-8.
8. Voss S, Gamez G, Hammerschmidt S. Impact of pneumococcal microbial surface components recognizing adhesive matrix molecules on colonization. Mol Oral Microbiol. 2012;27(4):246-56.
9. Agarwal V, Asmat TM, Luo S, Jensch I, Zipfel PF, Hammerschmidt S. Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem. 2010;285(30):23486-95.
10. Agarwal V, Hammerschmidt S, Malm S, Bergmann S, Riesbeck K, Blom AM. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J Immunol. 2012;189(7):3575-84.
11. Bergmann S, Lang A, Rohde M, Agarwal V, Rennemeier C, Grashoff C, Preissner KT, Hammerschmidt S. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J Cell Sci. 2009;122(Pt 2):256-67.
12. Bergmann S, Schoenen H, Hammerschmidt S. The interaction between bacterial enolase and plasminogen promotes adherence of Streptococcus pneumoniae to epithelial and endothelial cells. Int J Med Microbiol. 2013;303(8):452-62.
13. Dieudonne-Vatran A, Krentz S, Blom AM, Meri S, Henriques-Normark B, Riesbeck K, Albiger B. Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol. 2009;182(12):7865-77.
14. Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C, Zipfel PF. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J Immunol. 2007;178(9):5848-58.
15. Pracht D, Elm C, Gerber J, Bergmann S, Rohde M, Seiler M, Kim KS, Jenkinson HF, Nau R, Hammerschmidt S. PavA of Streptococcus pneumoniae modulates adherence, invasion, and meningeal inflammation. Infect Immun. 2005;73(5):2680-9.
16. Rennemeier C, Hammerschmidt S, Niemann S, Inamura S, Zahringer U, Kehrel BE. Thrombospondin-1 promotes cellular adherence of gram-positive pathogens via recognition of peptidoglycan. FASEB J. 2007;21(12):3118-32.
17. Agarwal V, Kuchipudi A, Fulde M, Riesbeck K, Bergmann S, Blom AM. Streptococcus pneumoniae endopeptidase O (PepO) is a multifunctional plasminogen- and fibronectin-binding protein, facilitating evasion of innate immunity and invasion of host cells. J Biol Chem. 2013;288(10):6849-63.
18. Agarwal V, Sroka M, Fulde M, Bergmann S, Riesbeck K, Blom AM. Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence. J Biol Chem. 2014;289(22):15833-44.
19. Brown EJ. Complement receptors and phagocytosis. Curr Opin Immunol. 1991;3(1):76-82.
20. Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol. 2014;32:433-59.
21. Carroll MC. The role of complement and complement receptors in induction and regulation of immunity. Annu Rev Immunol. 1998;16:545-68.
22. Kaya Z, Afanasyeva M, Wang Y, Dohmen KM, Schlichting J, Tretter T, Fairweather D, Holers VM, Rose NR. Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol. 2001;2(8):739-45.
23. Botto M, Walport MJ. C1q, autoimmunity and apoptosis. Immunobiology. 2002;205(4-5):395- 406.
24. Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785-97.
25. Naff GB, Pensky J, Lepow IH. The macromolecular nature of the first component of human complement. J Exp Med. 1964119:593-613.
26. Arlaud GJ, Gaboriaud C, Thielens NM, Budayova- Spano M, Rossi V, Fontecilla-Camps JC. Structural biology of the C1 complex of complement unveils the mechanisms of its activation and proteolytic activity. Mol Immunol. 2002;39(7-8):383-94.
27. Ghiran I, Tyagi SR, Klickstein LB, Nicholson- Weller A. Expression and function of C1q receptors and C1q binding proteins at the cell surface. Immunobiology. 2002;205(4-5):407-20.
28. Nayak A, Pednekar L, Reid KB, Kishore U. Complement and non-complement activating functions of C1q: a prototypical innate immune molecule. Innate Immun. 2012;18(2):350-63.
29. Gewurz H, Ying SC, Jiang H, Lint TF. Nonimmune activation of the classical complement pathway. Behring Inst Mitt. 1993;(93):138-47.
30. Ghebrehiwet B, Peerschke EI. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multiligand binding cellular proteins involved in inflammation and infection. Mol Immunol. 2004;41(2-3):173-83.
31. Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol. 2002;168(5):2441-8.
32. Xue Q, Gu C, Rivera J, Hook M, Chen X, Pozzi A, Xu Y. Entry of Bacillus anthracis spores into epithelial cells is mediated by the spore surface protein BclA, integrin alpha2beta1 and complement component C1q. Cell Microbiol. 2011;13(4):620-34.
33. Eggleton P, Tenner AJ, Reid KB. C1q receptors. Clin Exp Immunol. 2000;120(3):406-12.
34. Francis K, van Beek J, Canova C, Neal JW, Gasque P. Innate immunity and brain inflammation: the key role of complement. Expert Rev Mol Med. 2003;5(15):1-19.
35. Pisalyaput K, Tenner AJ. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. J Neurochem. 2008;104(3):696-707.
36. Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O. Platelets and infections - complex interactions with bacteria. Front Immunol. 2015;6:82.
37. Martin M, Leffler J, Blom AM. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem. 2012;287(40):33733-44.
38. Butko P, Nicholson-Weller A, Wessels MR. Role of complement component C1q in the IgGindependent opsonophagocytosis of group B streptococcus. J Immunol. 1999;163(5):2761-8.
39. Eads ME, Levy NJ, Kasper DL, Baker CJ, Nicholson-Weller A. Antibody-independent activation of C1 by type Ia group B streptococci. J Infect Dis. 1982;146(5):665-72.
40. Stemmer F, Loos M. Evidence for direct binding of the first component of complement, C1, to outer membrane proteins from Salmonella minnesota. Curr Top Microbiol Immunol. 1985;121:73-84.
41. Agarwal V, Ahl J, Riesbeck K, Blom AM. An alternative role of C1q in bacterial infections: facilitating Streptococcus pneumoniae adherence and invasion of host cells. J Immunol. 2013;191(8):4235-45.
42. Aubert B, Chesne S, Arlaud GJ, Colomb MG. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4. Biochem J. 1985;232(2):513-9.
43. Tenner AJ, Ziccardi RJ, Cooper NR. Antibodyindependent C1 activation by E. coli. J Immunol. 1984;133(2):886-91.
44. Alberti S, Marques G, Camprubi S, Merino S, Tomas JM, Vivanco F, Benedi VJ. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun. 1993;61(3):852-60.
45. Mintz CS, Arnold PI, Johnson W, Schultz DR. Antibody-independent binding of complement component C1q by Legionella pneumophila. Infect Immun. 1995;63(12):4939-43.
46. Koroleva IV, Sjoholm AG, Schalen C. Binding of complement subcomponent C1q to Streptococcus pyogenes: evidence for interactions with the M5 and FcRA76 proteins. FEMS Immunol Med Microbiol. 1998;20(1):11-20.
47. Terrasse R, Tacnet-Delorme P, Moriscot C, Pérard J, Schoehn G, Vernet T, Thielens NM, Di Guilmi AM, Frachet P. Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein. J Biol Chem. 2012;287(51):42620-33.
48. Roumenina LT, Popov KT, Bureeva SV, Kojouharova M, Gadjeva M, Rabheru S, Thakrar R, Kaplun A, Kishore U. Interaction of the globular domain of human C1q with Salmonella typhimurium lipopolysaccharide. Biochim Biophys Acta. 2008;1784(9):1271-6.
49. van den Berg RH, Faber-Krol MC, van de Klundert JA, van Es LA, Daha MR. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. J Immunol. 1996;156(11):4466-73.
50. Manderson AP, Botto M, Walport MJ. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol. 2004;22:431-56.
51. Topaloglu R, Bakkaloglu A, Slingsby JH, Aydintug O, Besbas N, Saatci U, Walport MJ. Survey of Turkish systemic lupus erythematosus patients for a particular mutation of C1Q deficiency. Clin Exp Rheumatol. 2000;18(1):75-7.
52. Botto M, Kirschfink M, Macor P, Pickering MC, Wurzner R, Tedesco F. Complement in human diseases: lessons from complement deficiencies. Mol Immunol. 2009;46(14):2774-83.
53. Ram S, Lewis LA, Rice PA. Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev. 2010;23(4):740-80.
54. Abeyta M, Hardy GG, Yother J. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun. 2003;71(1):218-258.
55. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun. 2007;75(1):83-90.
56. Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S, Henriques-Normark B. Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol. 2007;9(5):1162-71.
57. Winkelstein JA, Bocchini JA Jr, Schiffman G. The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol. 1976;116(2):367-70.
58. Mitchell TJ, Andrew PW, Saunders FK, Smith AN, Boulnois GJ. Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein. Mol Microbiol. 1991;5(8):1883-8.
59. Paton JC, Rowan-Kelly B, Ferrante A. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun. 1984;43(3):1085-7.
60. Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun. 1999;67(9):4720-4.
61. Janulczyk R, Iannelli F, Sjoholm AG, Pozzi G, Bjorck L. Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem. 2000;275(47):37257-63.
62. Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S. Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol. 2002;168(4):1886-94.
63. Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, Walport MJ, Botto M. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci U S A. 2002;99(26):16969-74.
64. Ali YM, Kenawy HI, Muhammad A, Sim RB, Andrew PW, Schwaeble WJ. Human L-ficolin, a recognition molecule of the lectin activation pathway of complement, activates complement by binding to pneumolysin, the major toxin of Streptococcus pneumoniae. PLoS One. 2013;8(12):e82583.
65. Stephens CG, Williams RC Jr, Reed WP. Classical and alternative complement pathway activation by pneumococci. Infect Immun. 1977;17(2):296-302.
66. Hammerschmidt S, Wolff S, Hocke A, Rosseau S, Muller E, Rohde M. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73(8):4653-67.
67. Weiser JN, Kapoor M. Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect Immun. 1999;67(7):3690-2.
68. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M, Tuomanen E. The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell. 2000;102(6):827-37.
69. Elm C, Braathen R, Bergmann S, Frank R, Vaerman JP, Kaetzel CS, Chhatwal GS, Johansen FE, Hammerschmidt S. Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem. 2004;279(8):6296-304.
70. Agarwal V, Hammerschmidt S. Cdc42 and the phosphatidylinositol 3-kinase-Akt pathway are essential for PspC-mediated internalization of pneumococci by respiratory epithelial cells. J Biol Chem. 2009;284(29):19427-36.
71. Voss S, Hallstrom T, Saleh M, Burchhardt G, Pribyl T, Singh B, Riesbeck K, Zipfel PF, Hammerschmidt S. The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J Biol Chem. 2013;288(22):15614-27.
72. Cundell DR, Gerard NP, Gerard C, Idanpaan- Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature. 1995;377(6548):435-8.
73. Radin JN, Orihuela CJ, Murti G, Guglielmo C, Murray PJ, Tuomanen EI. beta-Arrestin 1 participates in platelet-activating factor receptormediated endocytosis of Streptococcus pneumoniae. Infect Immun. 2005;73(12):7827-35.
74. Jensch I, Gamez G, Rothe M, Ebert S, Fulde M, Somplatzki D, Bergmann S, Petruschka L, Rohde M, Nau R, Hammerschmidt S. PavB is a surface-exposed adhesin of Streptococcus pneumoniae contributing to nasopharyngeal colonization and airways infections. Mol Microbiol. 2010;77(1):22-43.
75. Yamaguchi M, Terao Y, Mori Y, Hamada S, Kawabata S. PfbA, a novel plasmin- and fibronectin-binding protein of Streptococcus pneumoniae, contributes to fibronectin-dependent adhesion and antiphagocytosis. J Biol Chem. 2008;283(52):36272-9.
76. Hilleringmann M, Giusti F, Baudner BC, Masignani V, Covacci A, Rappuoli R, Barocchi MA, Ferlenghi I. Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg A. PLoS Pathog. 2008;4(3):e1000026.
77. Moschioni M, Emolo C, Biagini M, Maccari S, Pansegrau W, Donati C, Hilleringmann M, Ferlenghi I, Ruggiero P, Sinisi A, Pizza M, Norais N, Barocchi MA, Masignani V. The two variants of the Streptococcus pneumoniae pilus 1 RrgA adhesin retain the same function and elicit cross-protection in vivo. Infect Immun. 2010;78(12):5033-42.
78. Bergmann S, Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost. 2007;98(3):512-20.
79. Singh AK, Pluvinage B, Higgins MA, Dalia AB, Woodiga SA, Flynn M, Lloyd AR, Weiser JN, Stubbs KA, Boraston AB, King SJ. Unravelling the Multiple functions of the architecturally intricate Streptococcus pneumoniae beta-galactosidase, BgaA. PLoS Pathog. 2014;10(9):e1004364.
80. Mohan S, Hertweck C, Dudda A, Hammerschmidt S, Skerka C, Hallstrom T, Zipfel PF. Tuf of Streptococcus pneumoniae is a surface displayed human complement regulator binding protein. Mol Immunol. 2014;62(1):249-64.
81. Zipfel PF, Hallstrom T, Hammerschmidt S, Skerka C. The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci. Vaccine. 2008;26(Suppl 8):I67-74.
82. Agarwal J, Agarwal G, Ayyagari A, Kar DK, Mishra SK, Bhatia E. Isolated Pneumocystis carinii infection of adrenal glands causing Addison's disease in a non-immunocompromised adult. Endocr Pathol. 2001;12(1):87-91.
83. Yuste J, Botto M, Bottoms SE, Brown JS. Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog. 2007;3(9):1208-19.
84. Yuste J, Sen A, Truedsson L, Jonsson G, Tay LS, Hyams C, Baxendale HE, Goldblatt F, Botto M, Brown JS. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect Immun. 2008;76(8):3761-70.
85. Kang YS, Do Y, Lee HK, Park SH, Cheong C, Lynch RM, Loeffler JM, Steinman RM, Park CG. A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q. Cell. 2006;125(1):47-58.
86. Domenech M, Ramos-Sevillano E, Garcia E, Moscoso M, Yuste J. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect Immun. 2013;81(7):2606-15.
87. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect Immun. 2010;78(2):704-15.
88. Quin LR, Moore QC 3rd, McDaniel LS. Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice. Infect Immun. 2007;75(4):2067-70.
89. Alcantara RB, Preheim LC, Gentry MJ. Role of pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats. Infect Immun. 1999;67(6):2862-6.
90. Almeda S, Rosenberg RD, Bing DH. The binding properties of human complement component C1q. Interaction with mucopolysaccharides. J Biol Chem. 1983;258(2):785-91.
91. Zutter MM, Edelson BT. The alpha2beta1 integrin: a novel collectin/C1q receptor. Immunobiology. 2007;212(4-5):343-53.
92. Nowicki S, Martens MG, Nowicki BJ. Gonococcal infection in a nonhuman host is determined by human complement C1q. Infect Immun. 1995;63(12):4790-4.:e1004364.